AXONA OFFERS NEW APPROACH TO MANAGING ALZHEIMER'S DISEASE

Soundbites

Axona is a new first-in-class prescription medical food for the clinical dietary management of the metabolic processes associated with mild-to-moderate Alzheimer’s disease. In clinical trials Axona has been shown to safely improve cognitive function and memory in AD patients.

  • Jeffrey Cummings, M.D., Neurologist & Director, Mary S. Easton Center for Alzheimer's Disease Research at UCLA, consultant to Accera
  • Steve Orndorff, Ph.D., Founder & CEO, Accera, Inc.

B-Roll

*** Product Shots**MOA Video***Making Axona Drink***Doctor Demonstrating Computer Brain Scans***

Hi-Res Photo

Axona Packaging

Video Provided By: "Accera, Inc."

Click here for more broadcast video & audio news releases and other source material from PR Newswire.

Send Feedback

 Assets For This Story

  Hardcopy Request

NOTE: All requests received before 5:00PM Eastern Time are shipped next day delivery (10:30 AM) unless otherwise specified. If you need faster turnaround time, please call 1-800-653-5313 option 2 and we can make the appropriate arrangements.

 Please submit the following information.
First Name: *
Last Name: *
Station Call Letters: *
Address 1: *
Address 2:
City: *
State: *
Zip: *
Phone Number: *
(Required by overnight delivery carrier)
Email Address: *
Delivery Time: *
Comments:
 
  * Required field.

Use the icons above for more information or call MultiVu Media Relations at 1-800-653-5313 Option 3 or e-mail us or click here for help.